Medical Weight Loss for Chester, Pennsylvania Residents

Chester, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Chester through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Pennsylvania: there is no local Chester office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why Chester Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Chester is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across Pennsylvania trust us to guide a serious decision about their health.

Chester is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

Our clinic sits in Costa Mesa, California, but if you live in Chester, Pennsylvania, you receive the exact same physician-supervised care from Dr. Anjmun Sharma over telehealth, with no drive and no waiting room. We care for patients throughout downtown Chester and the greater Delaware County area of the Philadelphia metro. Your plan is shaped around your own history, the medications you have tried, and the goals you bring, not a one-size template applied to every Chester patient.

Because your care happens by telehealth, there is no waitlist to clear and most Chester patients can have their physician visit scheduled within the same week. Please note that our compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical, and results vary from person to person. Pennsylvania is one of the most populous states in the country, and New Hope Weight Loss serves patients across it by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Compounded GLP-1 care, supervised by a physician

The 90-Day Metabolic Reset is built on semaglutide, the same active ingredient you will find in Wegovy and Ozempic. It is priced from $166/mo, with the complete 90-day program at $499, and branded-drug trials averaged about 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved, not brand-identical, and results vary by person. Dr. Sharma manages your care by telehealth, wherever you are in Chester.

Prefer the dual-action route? Tirzepatide

From $233/mo, tirzepatide works on GLP-1 and GIP together. In branded-drug trials, dose-qualified patients reached up to 22.5 percent loss, a peak number that is not typical. Same active ingredient as Mounjaro and Zepbound.

It all starts with a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Chester

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across Chester. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your Chester address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, Chester

Is there somewhere in Chester I can visit New Hope Weight Loss?

There is no physical office in Chester. We work from a single clinic in Costa Mesa, California, and care for Chester, Pennsylvania patients by telehealth. Your candidacy for a compounded GLP-1 plan is confirmed when Dr. Anjmun Sharma reviews your health information during an online video appointment.

Will Chester patients have to make any in-person trips?

No trips are necessary. We provide care to Chester completely through telehealth, covering consults, follow-up visits, and ongoing support remotely. Once Dr. Sharma signs off, your compounded semaglutide or tirzepatide is delivered to Chester in cold-pack shipping that preserves the correct temperature.

What does the program cost a Chester patient?

Budget $119 for the physician visit. Semaglutide is priced from $166 monthly or $499 for 90 days, and tirzepatide from $233 monthly. The medication is a separate line item. We accept HSA, FSA, Klarna, and Affirm, and no distance surcharge is added for patients located in Chester.

What areas of Chester do you serve?

We serve patients from across Chester by telehealth, including downtown Chester and the greater Delaware County area of the Philadelphia metro.

How does compounded medication compare on cost for Chester patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Chester patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Chester Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Chester, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.